Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Ellebaek · SciRah

Researcher profile · Semantic Scholar

E. Ellebaek

Share profile

E. Ellebaek — researcher profile on SciRah

h-index: 22
Works: 123
Citations: 2,283

Most-cited papers

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
M. Rohaan, T. H. Borch, J. H. van den Berg, Ö. Met +53 more
2022New England Journal of Medicine452 citations Open access
Semantic Scholar
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
R. Andersen, M. Donia, E. Ellebaek, T. H. Borch +8 more
2016Clinical Cancer Research279 citations
Semantic Scholar
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
J. Kjeldsen, C. Lorentzen, E. Martinenaite, E. Ellebaek +13 more
2022Nature Medicine161 citations Open access
Semantic Scholar
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study.
P. Kongsted, T. H. Borch, E. Ellebaek, T. Z. Iversen +6 more
2017Cytotherapy85 citations
Semantic Scholar
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
K. Bol, E. Ellebaek, L. Hoejberg, M. Bagger +8 more
2019Cancers56 citations Open access
Semantic Scholar
The real-world impact of modern treatments on the survival of patients with metastatic melanoma.
M. Donia, E. Ellebaek, T. Øllegaard, Lone Duval +6 more
2019European Journal of Cancer47 citations
Semantic Scholar
The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients.
E. Ellebaek, I. Svane, H. Schmidt, C. Haslund +6 more
2021Cancer Epidemiology44 citations Open access
Semantic Scholar
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
T. H. Borch, R. Andersen, E. Ellebaek, Ö. Met +2 more
2020Journal for ImmunoTherapy of Cancer42 citations Open access
Semantic Scholar
Cutaneous adverse reactions to anti-PD-1 treatment - a systematic review.
A. Simonsen, J. Kaae, E. Ellebaek, I. Svane +1 more
2020Journal of American Academy of Dermatology40 citations
Semantic Scholar
Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors.
Nicole A Romanski, R. Holmstroem, E. Ellebaek, I. Svane
2020European Journal of Cancer37 citations
Semantic Scholar
PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma.
E. Ellebaek, Shawez Khan, L. Bastholt, Henrik Schmidt +3 more
2023European Journal of Cancer32 citations Open access
Semantic Scholar
Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
M. D. de Meza, R. Ismail, D. Rauwerdink, Olivier J. van Not +24 more
2021European Journal of Cancer32 citations Open access
Semantic Scholar
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
J. Kjeldsen, C. Lorentzen, E. Martinenaite, E. Ellebaek +13 more
2021Nature Medicine29 citations Open access
Semantic Scholar
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report
R. Holmstroem, E. Dahl, M. Helms, H. Nielsen +5 more
2022BMJ Open Gastroenterology26 citations Open access
Semantic Scholar
Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma
T. Monberg, S. Pakola, B. Albieri, E. Ellebaek +25 more
2025Cell Reports Medicine25 citations Open access
Semantic Scholar
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022).
S. Pedersen, E. L. Johansen, K. Højholt, Maria Pedersen +9 more
2025European Journal of Cancer21 citations Open access
Semantic Scholar
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
S. Buschow, M. Ramazzotti, Inge M. J. Reinieren-Beeren, L. Heinzerling +18 more
2017OncoTarget20 citations Open access
Semantic Scholar
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
S. Pedersen, R. Holmstroem, Annika von Heymann, L. Tolstrup +8 more
2023Acta oncologica18 citations Open access
Semantic Scholar
Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab
I. Noringriis, M. Donia, K. Madsen, Henrik Schmidt +4 more
2025British Journal of Cancer17 citations Open access
Semantic Scholar
Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028
M. Donia, H. Jespersen, M. Jalving, R. Lee +16 more
2025ESMO Open16 citations Open access
Semantic Scholar
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 - Seasonal variation and association with outcome.
R. Jurlander, L. M. Guldbrandt, R. Holmstroem, K. Madsen +7 more
2024European Journal of Cancer15 citations Open access
Semantic Scholar
Clinical value of routine [18F]2‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma
E. Ellebaek, A. Schina, R. Andersen, H. Hendel +2 more
2022International Journal of Cancer14 citations Open access
Semantic Scholar
Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting
S. Pedersen, K. O. Larsen, A. Christensen, I. Svane +2 more
2021Acta oncologica13 citations Open access
Semantic Scholar
The real-world impact of modern treatments on the survival of patients with metastatic melanoma.
M. Donia, E. Ellebaek, T. Øllegaard, Lone Duval +6 more
2018Annals of Oncology13 citations Open access
Semantic Scholar
Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma.
R. Holmstroem, S. Pedersen, R. Jurlander, K. Madsen +7 more
2024European Journal of Cancer12 citations Open access
Semantic Scholar
Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapies.
A. Schina, S. Pedersen, Anne-Louise Spenning, O. K. Laursen +7 more
2023European Journal of Cancer12 citations Open access
Semantic Scholar
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma
T. J. Monberg, T. Kudling, B. Albieri, S. Pakola +16 more
2024Immuno-Oncology Technology10 citations Open access
Semantic Scholar
Real-world data on melanoma brain metastases and survival outcome
S. Pedersen, Søren Møller, M. Donia, G. Persson +2 more
2022Melanoma research10 citations
Semantic Scholar
Does patient sex affect the treatment outcome of immune checkpoint inhibitors? A Danish, observational melanoma study.
S. Petersen, C. R. Hansen, E. Ellebaek, Henrik Schmidt +3 more
2024European Journal of Cancer9 citations Open access
Semantic Scholar
Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic Melanoma
A. V. Soerensen, E. Ellebaek, L. Bastholt, H. Schmidt +2 more
2020Cancers9 citations Open access
Semantic Scholar
Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkers.
E. Ellebaek, M. Donia, I. Svane
2025European Journal of Cancer8 citations Open access
Semantic Scholar
Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma
E. Ellebaek, A. Schina, H. Schmidt, C. Haslund +3 more
2022Pigment Cell & Melanoma Research8 citations Open access
Semantic Scholar
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study.
M. Weichenthal, E. Ellebaek, J. Mangana, N. Asher +44 more
2025European Journal of Cancer7 citations Open access
Semantic Scholar
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib
S. Pedersen, M. Nielsen, M. Donia, I. Svane +2 more
2024Cancers7 citations Open access
Semantic Scholar
EMRseq: Registry-based outcome analysis on 1,000 patients with BRAF V600–mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition.
M. Weichenthal, I. Svane, Lidija Kandolf Sekulovič, J. Mangana +16 more
2022Journal of Clinical Oncology7 citations
Semantic Scholar
The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma
C. Vestergaard, E. Ellebaek, T. H. Borch, M. Donia +1 more
2025American Journal of Clinical Dermatology6 citations
Semantic Scholar
Impact of Metastatic Pattern on Survival in Patients with Posterior Uveal Melanoma: A Retrospective Cohort Study
T. G. Hindso, Peter S Jensen, M. B. Sjøl, Kristoffer Nissen +10 more
2024Cancers6 citations Open access
Semantic Scholar
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases—A Danish Real-World Cohort
Karoline Dreyer Kattenhøj, Christine Louise Møberg, L. M. Guldbrandt, R. Friis +7 more
2024Cancers6 citations Open access
Semantic Scholar
18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma
T. G. Hindso, T. Martinussen, C. W. Bjerrum, S. H. Keller +10 more
2025Scientific Reports5 citations Open access
Semantic Scholar
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
Morten Fink, A. Vittrup, L. Bastholt, I. Svane +9 more
2021Cancers5 citations Open access
Semantic Scholar
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression
Sif Homburg, C. B. Christensen, M. Pedersen, S. Sørensen +4 more
2024Cancers4 citations Open access
Semantic Scholar
1032TiP A phase I, first-in-human, study of TILT-123, a tumor-selective oncolytic adenovirus encoding TNFa and IL-2, in participants with advanced melanoma receiving adoptive T-cell therapy with tumor-infiltrating lymphocytes
I. Svane, J. Santos, V. Cervera-Carrascón, R. Havunen +7 more
2021Annals of Oncology4 citations Open access
Semantic Scholar
514 Biomarker insights and long-term outcomes of TILT-123 oncolytic adenovirus combined with tumor-infiltrating lymphocytes in refractory metastatic melanoma: results from the TUNINTIL phase 1 trial
T. Kudling, L. Haybout, James H. A. Clubb, T. Monberg +15 more
2025Regular and Young Investigator Award Abstracts3 citations Open access
Semantic Scholar
Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study.
N. Asher, Peter Mohr, E. Ellebaek, Marc Bender +9 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study
S. K. Christensen, M. Winther, Ida J Laursen, F. S. Madsen +11 more
2024Supportive Care in Cancer3 citations Open access
Semantic Scholar
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis
R. Holmstroem, A. S. Teisner, M. W. Sweep, I. Noringriis +18 more
2026Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar
Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC.
Rikke Andersen, Mette Syberg Jespersen, M. Presti, B. Bjørnhart +32 more
2026European Journal of Cancer2 citations Open access
Semantic Scholar
Impact of assessment-to-treatment interval and metastatic biopsy site on the predictive value of PD-L1 expression at the 1 % cut-off level in melanoma.
C. Vestergaard, M. Donia, K. Madsen, H. Schmidt +4 more
2025European Journal of Cancer2 citations Open access
Semantic Scholar
Neutralizing antibodies and lymphocyte count as biomarkers in patients receiving oncolytic adenovirus TILT-123 and adoptive cell transfer of tumor-infiltrating lymphocytes for metastatic melanoma refractory to immune checkpoint inhibitors.
L. Haybout, J. Clubb, T. Monberg, S. Pakola +16 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
T. H. Borch, Rikke Andersen, H. Hendel, K. Madsen +2 more
2025Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Donia×35
Invite
M. Donia — researcher profile on SciRah
I. Svane×29
Invite
I. Svane — researcher profile on SciRah
C. Haslund×13
Invite
C. Haslund — researcher profile on SciRah
L. Bastholt×11
Invite
L. Bastholt — researcher profile on SciRah

×10

Invite

R. Holmstroem — researcher profile on SciRah

Invite

I. Svane — researcher profile on SciRah

Invite

H. Schmidt — researcher profile on SciRah

Invite

T. H. Borch — researcher profile on SciRah

Invite

L. Bastholt — researcher profile on SciRah

Invite

T. Monberg — researcher profile on SciRah

Henrik Schmidt×6

Invite

Henrik Schmidt — researcher profile on SciRah

Invite

K. Madsen — researcher profile on SciRah